WallStreetZenWallStreetZen

NYSE: DHR
Danaher Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DHR past earnings growth

How has DHR's earnings growth performed historically?
Company
14.71%
Industry
2.2%
Market
39.91%
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DHR's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DHR past revenue growth

How has DHR's revenue growth performed historically?
Company
11.35%
Industry
12.79%
Market
167.32%
DHR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DHR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DHR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DHR earnings and revenue history

Current Revenue
$31.3B
Current Earnings
$6.6B
Current Profit Margin
21.2%
DHR's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DHR Return on Equity

Current Company
14.3%
Current Industry
78%
Current Market
-8.3%
DHR's Return on Equity (14.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DHR announces earnings.

DHR Return on Assets

Current Company
8.1%
Current Industry
6.3%
DHR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DHR Return on Capital Employed

Current Company
11.48%
Current Industry
10.8%
DHR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DHR vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DHR$31.25B$10.63B$6.64B+11.88%+21.89%
TMO$44.17B$11.60B$7.03B+17.38%+24.82%
A$6.85B$1.91B$1.25B+8.90%+14.60%
IQV$14.31B$2.87B$1.18B+8.63%+2.55%
DXCM$2.79B$432.20M$230.00M+33.09%+48.91%
View Top Diagnostic & Research Stocks

Danaher Earnings & Revenue FAQ

What were DHR's earnings last quarter?

On Invalid Date, Danaher (NYSE: DHR) reported Q3 2022 earnings per share (EPS) of $2.13, up 36.54% year over year. Total Danaher earnings for the quarter were $1.55 billion. In the same quarter last year, Danaher's earnings per share (EPS) was $1.56.

If you're new to stock investing, here's how to buy Danaher stock.

What was DHR's earnings growth in the past year?

As of Q1 2023, Danaher's earnings has grown 14.71% year over year. This is 12.51 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 2.2%. Danaher's earnings in the past year totalled $6.64 billion.

What was DHR's revenue last quarter?

On Invalid Date, Danaher (NYSE: DHR) reported Q3 2022 revenue of $7.66 billion up 6% year over year. In the same quarter last year, Danaher's revenue was $7.23 billion.

What was DHR's revenue growth in the past year?

As of Q1 2023, Danaher's revenue has grown 11.35% year over year. This is 1.44 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 12.79%. Danaher's revenue in the past year totalled $31.25 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.